Skip to content
by Legal Desire
25 August 2020

Latham & Watkins Advises Harmony Biosciences Holdings, Inc. in IPO

Advising firms

Deal team

18 lawyers named
LawyerFirmSeniorityPracticeOffice
Christopher Lueking Lead Latham & Watkins LLP Partner corporate Chicago
Mark Gerstein Lead Latham & Watkins LLP Partner corporate Chicago
Jonathan Sarna Latham & Watkins LLP Associate corporate Not stated
Scott Westhoff Latham & Watkins LLP Associate corporate Not stated
KC Sands Latham & Watkins LLP Associate corporate Not stated
Ryan Hudson Latham & Watkins LLP Associate corporate Not stated
Alex Cohen Latham & Watkins LLP Partner securities law Washington, D.C.
Paul Dudek Latham & Watkins LLP Partner securities law Washington, D.C.
Michelle Carpenter Latham & Watkins LLP Partner benefits and compensation Los Angeles
Jordan David Latham & Watkins LLP Associate benefits and compensation Not stated
Will Hackett Latham & Watkins LLP Associate public company representation Washington, D.C.
Charlie Guinn Latham & Watkins LLP Associate public company representation Washington, D.C.
Elizabeth Richards Latham & Watkins LLP Partner healthcare and life sciences Washington, D.C.
Chris Hazuka Latham & Watkins LLP Partner healthcare and life sciences Silicon Valley
Betty Pang Latham & Watkins LLP Counsel healthcare and life sciences Not stated
Barrett Tenbarge Latham & Watkins LLP Associate healthcare and life sciences Not stated
Rob Yeh Latham & Watkins LLP Associate healthcare and life sciences Not stated
Rene de Vera Latham & Watkins LLP Partner tax Chicago

Stated terms

Stated value
USD 148m (US$147.6 million)
What the figure measures
Issue size
Client
Harmony Biosciences Holdings, Inc.Issuer
Counterparties
Not stated